Morphic Holding Inc (NAS:MORF)
$ 56.99 0 (0%) Market Cap: 2.86 Bil Enterprise Value: 2.24 Bil PE Ratio: 0 PB Ratio: 4.62 GF Score: 42/100

Q4 2020 Morphic Holding Inc Earnings Call Transcript

Mar 01, 2021 / 01:00PM GMT
Release Date Price: $84.85 (+134.65%)
Operator

Excuse me, ladies and gentlemen, this is the operator. My name is Myra. Thank you for standing by and welcome to the Morphic Financial and Operational Results 2020 Year-End Conference Call. At this time, all participants are in a listen-only mode. After the speaker presentation, there will be a question-and-answer session. (Operator Instructions).

With that I would now like to hand the conference over to our first speaker, Chris Erdman, Senior Vice President of Communications. Thank you, and please go ahead.

Chris Erdman
Morphic Therapeutic - Senior Vice President of Communications

Thank you, Myra, and good morning, everyone. Thanks for attending Morphic's first investor call. Today, we will review our 2020 operational and financial results and also provide an update on the ongoing Phase 1 clinical trial of MORF-057.

A little housekeeping. This morning, we issued two press releases. The first reported results for the fourth quarter and full-year ended December 31, 2020, and the second announced the preliminary positive results from the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot